MedPath

Dry Needling Dosage in the Treatment of Myofascial Neck Pain

Not Applicable
Completed
Conditions
Neck Pain
Registration Number
NCT02190890
Lead Sponsor
Universidad Rey Juan Carlos
Brief Summary

The purpose of this study are (1) to determine the effectiveness of different dry needling dosages in the treatment of myofascial trigger points in the upper trapezius muscle in patients with myofascial neck pain, (2) to assess postneedling soreness and tenderness and (3) evaluate the influence of psychological factors on the perception of postneedling soreness.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
94
Inclusion Criteria
  • Diagnosis of an active myofascial trigger point. Neck pain: Superior to 3 cm in VAS
Exclusion Criteria
  • Neck area: Fracture, radiculopathy, previous surgery, previous needling treatment in the last 6 months, previous analgesic medication (24 hours), psychiatric disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postneedling soreness1 week

Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).

Pain1 week

Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).

Secondary Outcome Measures
NameTimeMethod
Psychological factorsPre-intervention

Pain Catastrophizing Scale

Pressure pain threshold1 week

Three consecutive trials of pressure pain threshold on the active trigger point at a rate of 1 kg/sec at intervals of 30 seconds were conducted.

Pain in cervical range of motion1 week

Pain in a numerical pain rating scale during all cervical movements was recorded.

Neck disability1 week

Neck Disability Index questionnarie was completed.

Cervical range of motion1 week

The subjects sat in a chair and a CROM goniometer was placed over the head. They were asked to perform active neck movements to the fullest extent of their mobility. Each movement was recorded three times and the average value was calculated.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.